Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, November 2001, p. 1136-1139, Vol. 8, No. 6
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.6.1136-1139.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Passive Immunization with Milk Produced from an Immunized Cow
Prevents Oral Recolonization by Streptococcus
mutans
Yoshihiro
Shimazaki,1
Morihide
Mitoma,1
Takahiko
Oho,1
Yoshio
Nakano,1
Yoshihisa
Yamashita,2
Kaoru
Okano,3
Yutaka
Nakano,3
Masataka
Fukuyama,3
Noboru
Fujihara,4
Youichi
Nada,3 and
Toshihiko
Koga1,*
Department of Preventive Dentistry, Kyushu
University Faculty of Dental Science, Fukuoka
812-8582,1 Department of Oral Health,
Nihon University School of Dentistry, Tokyo,
010-8310,2 University Farm, Kyushu
University Faculty of Agriculture, Fukuoka
811-2307,3 and Department of Animal and
Marine Bioresource Science, Kyushu University Faculty of
Agriculture, Fukuoka 812-8581,4 Japan
Received 9 May 2001/Returned for modification 23 July 2001/Accepted 17 August 2001
 |
ABSTRACT |
Cell surface protein antigen (PAc) and water-insoluble
glucan-synthesizing enzyme (GTF-I) produced by cariogenic
Streptococcus mutans are two major factors implicated in
the colonization of the human oral cavity by this bacterium. We
examined the effect of bovine milk, produced after immunization with a
fusion protein of functional domains of these proteins, on the
recolonization of S. mutans. To prepare immune milk,
a pregnant Holstein cow was immunized with the fusion protein
PAcA-GB, a fusion of the saliva-binding alanine-rich region (PAcA) of
PAc and the glucan-binding (GB) domain of GTF-I. After eight adult
subjects received cetylpyridinium chloride (CPC) treatment, one
subgroup (n = 4) rinsed their mouths with immune milk
and a control group (n = 4) rinsed with nonimmune milk. S. mutans levels in saliva and dental plaque
decreased after CPC treatment in both groups. Mouth rinsing with immune
milk significantly inhibited recolonization of S. mutans in
saliva and plaque. On the other hand, the numbers of S. mutans cells in saliva and plaque in the control group increased
immediately after the CPC treatment and surpassed the baseline level 42 and 28 days, respectively, after the CPC treatment. The ratios of
S. mutans to total streptococci in saliva and plaque in the
group that received immune milk were lower than those in the control
group. These results suggest that milk produced from immunized cow may
be useful for controlling S. mutans in the human oral cavity.
 |
INTRODUCTION |
Dental caries is one of the most
prevalent infectious diseases in humans, and Streptococcus
mutans has been implicated as a causative organism in human dental
caries (5, 12, 22). Colonization on tooth surfaces by this
microorganism is considered to be the first step in the induction of
dental caries. S. mutans adheres to tooth surfaces by
sucrose-independent and sucrose-dependent mechanisms (8,
10). The former mechanism is due to the binding of a 190-kDa
surface protein antigen (PAc) of S. mutans to human salivary
components on tooth surfaces (9). The latter,
sucrose-dependent binding, is due to the synthesis of water-insoluble
glucan from sucrose catalyzed by glucosyltransferases (GTFs)
(11). The important roles of PAc and
water-insoluble-glucan-synthesizing GTF (GTF-I) in the
cariogenicity of S. mutans make them rational targets
for the development of an anticaries vaccine and an adhesion inhibitor (7). Simultaneous inhibition of these colonization factors may result in the protection of teeth from dental caries.
We previously constructed a fusion protein, PAcA-GB, that fuses the
saliva-binding alanine-rich region (PAcA) of PAc with the
glucan-binding (GB) domain of GTF-I (27) and have
immunized Holstein cows with the fusion protein (19).
Moreover, we have shown that antibodies purified from the milk of these
immunized Holstein cows inhibit both the adhesion of S. mutans to saliva-coated hydroxyapatite beads and glucan synthesis
by GTF-I (19). In this study, we investigated the effect
of passive immunization with milk from an immunized cow on
recolonization of the human oral cavity by S. mutans.
 |
MATERIALS AND METHODS |
Preparation of immune milk and control milk.
Immune milk and
control milk were prepared as described previously (19).
Immune milk was collected from a Holstein cow immunized with the fusion
protein PAcA-GB (27), and control milk was collected from
a Holstein cow that had not been immunized. After pasteurization at
65°C for 30 min, milk from each cow was processed and stored at
30°C until it was used.
rPAc and GTF-I.
Recombinant PAc (rPAc) and GTF-I were used
as antigens for the enzyme-linked immunosorbent assay (ELISA). rPAc was
purified from the culture supernatants of transformant S. mutans TK18 by ammonium sulfate precipitation, chromatography on
DEAE-cellulose, and subsequent gel filtration on Sepharose CL-6B
(Pharmacia, Uppsala, Sweden) (9). For preparation of
GTF-I, transformant S. mutans UA130B+, which is
defective in both the gtfC and gtfD gene products
(27), was grown in brain heart infusion broth (Difco
Laboratories, Detroit, Mich.) at 37°C for 18 h. GFT-I was
extracted from whole cells of the transformant by treatment with 8 M
urea at 25°C for 1 h. The extract was centrifuged at
5,000 × g for 20 min, and the supernatant was dialyzed
against 10 mM potassium phosphate buffer (pH 6.0). The supernatant was
used as the GTF-I preparation (27).
ELISA.
For ELISA, 96-well microtiter plates were coated with
100 µl of rPAc or GTF-I (5 µg/ml) in 50 mM carbonate-bicarbonate
buffer (pH 9.6). After incubation at 37°C for 90 min, the plates were washed with phosphate-buffered saline (PBS) containing 0.05% (vol/vol) Tween 20 (PBST) and blocked with PBST containing 1% (wt/vol) chicken egg albumin at 37°C for 90 min. After the plates were washed
three times with PBST, twofold serial dilutions of pasteurized bovine milk were added (100 µl per well) and the plates were incubated at
37°C for 90 min. The bound antibodies were detected with alkaline phosphatase-conjugated rabbit anti-bovine immunoglobulin G (heavy and
light chains) (Zymed Laboratories, South San Francisco, Calif.) followed by the addition of p-nitrophenylphosphate substrate
solution (1 mg/ml). After 30 min of incubation at 37°C, the
A405 was measured with a microplate reader
(Bio-Rad Laboratories, Richmond, Calif.). The ELISA antibody titer was
expressed as the reciprocal of the highest dilution giving an
A405 of 0.1 above the conjugated control (no
sample added) after 30 min of incubation with the substrate.
Subjects.
Eight healthy volunteers (ages 20 to 25) who had
more than 5 × 105 CFU of S. mutans/ml in
stimulated saliva were randomly divided into test (n = 4; 3 female, 1 male) and control (n = 4; 2 female, 2 male) groups. Written informed consent was obtained from all volunteers, and the protocol was approved by the ethics committee of
the Faculty of Dental Science, Kyushu University, Fukuoka, Japan. None
of the volunteers had any clinically detectable active carious lesions.
For the baseline values of the mean S. mutans count, the
ratio of S. mutans to total streptococci, and the mean dental caries experience (decayed, missing, filled teeth), there was no statistical difference between the groups.
Experimental design.
Three different samples of saliva and
plaque were collected from each subject during a 2-week period. The
baseline S. mutans level in each subject was determined from
the mean value of the three samples. Before rinsing their mouths with
milk, all of the subjects received cetylpyridinium chloride (CPC)
treatment and professional mechanical tooth cleaning (PMTC) for 5 days
to lower the level of S. mutans in the oral cavity. After
PMTC with a rubber cup and an abrasive containing fluoride, 10 ml of
1.0% CPC solution was applied once a day for 5 min using a custom-made
dentition tray. During this treatment period, the subjects also rinsed
their mouths with 10 ml of 0.2% CPC solution for 1 min twice a day
(morning and night) after brushing their teeth. On the day after the
last CPC treatment, they started rinsing their mouths with milk. Mouth rinsing was performed with 10 ml of immune and control milk for 1 min
twice a day (morning and night) after tooth brushing for a period of 14 days. The subjects were instructed not to change their oral hygiene
habits during the study period, and they were asked to refrain from
eating and drinking for 1 h after rinsing their mouths with CPC or milk.
Bacteriological analysis.
Stimulated whole saliva was
collected by having the subjects chew paraffin and expectorate into a
tube chilled on ice. Plaque samples collected using a sterilized
periodontal probe from all the surfaces of the most posterior molars in
each quadrant were immediately placed into 1 ml of PBS. Both saliva and
plaque samples were homogenized by sonication for 10 s. Serial
10-fold dilutions of the suspensions were prepared in PBS. Aliquots of
100 µl of the appropriate dilutions were plated in duplicate on mitis
salivarius (MS) agar and MS-bacitracin (MS-B) agar (2).
The plates were incubated at 37°C under anaerobic conditions for
72 h. The number of S. mutans cells and the total
number of streptococci per plate were determined by counting colonies
on MS-B agar and MS agar plates, respectively. Identification of
S. mutans was conducted by observation of colony
morphology on MS-B agar plates under a microscope, and representative
colonies of different morphotypes identified as S. mutans
were confirmed by the PCR method as described previously
(20).
Statistical analysis.
The ELISA titer, S. mutans
count, and ratio of S. mutans to total streptococci were
each expressed as the mean ± standard deviation. Statistical
comparison between the test group and the control group was made using
the Mann-Whitney U test with SPSS (version 6.1; SPSS Japan Inc., Tokyo, Japan).
 |
RESULTS |
ELISA titers in milk.
ELISA titers to rPAc and GTF-I of immune
milk from a cow immunized with fusion protein PAcA-GB and control milk
from a nonimmunized cow are shown in Table
1. Immune milk showed antibody titers to
the two components of the fusion protein, rPAc and GTF-I, approximately 130- and 10-fold higher, respectively, than those of the control milk.
S. mutans count.
The numbers of S. mutans cells in saliva and dental plaque were expressed as the
mean of the percentage of the baseline count (Fig.
1). S. mutans in saliva and
plaque was suppressed by the CPC and PMTC treatments in both the test
group and the control group. The numbers of S. mutans cells
in saliva and plaque in the test group remained less than 1/10 of the
baseline throughout the 4 weeks after mouth rinsing was begun. On the
other hand, the numbers of S. mutans cells in saliva and
plaque in the control group returned to near-baseline levels during the
period of mouth rinsing and increased beyond the baseline after the end
of the mouth rinsing.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
Effects of milk from an immunized cow on oral
recolonization by S. mutans in saliva (A) and dental plaque
(B). The volunteers rinsed with milk (solid circles) from a Holstein
cow immunized with fusion protein PAcA-GB or with control milk (open
circles) (10 ml/rinse) twice a day (morning and night) after brushing
for 14 days after an initial 5 days of CPC treatment. The values are
the mean + standard deviation of S. mutans levels
expressed as a percentage of the baseline S. mutans level.
The statistical difference between the baseline S. mutans
level and the S. mutans level at each sampling date was
assessed using the Mann-Whitney U test. *, P < 0.1;
**, P < 0.05.
|
|
Ratio of S. mutans to total streptococci.
In the
test group, the ratios of S. mutans to total streptococci in
saliva and plaque decreased after the CPC treatment and PMTC and
further decreased during the first week of mouth rinsing with the
immune milk (Fig. 2). From the second
week of mouth rinsing, the ratios increased gradually. On the other
hand, the ratio of S. mutans to total streptococci in plaque
in the control group increased immediately after the CPC treatment and
PMTC and continued to increase beyond the baseline level. The ratios of
S. mutans to total streptococci in the test group were lower
than in the control group throughout the study period.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
Effects of milk from an immunized cow on the ratio of
S. mutans to total streptococci in saliva (A) and dental
plaque (B). The volunteers rinsed with milk (solid circles) from a
Holstein cow immunized with fusion protein PAcA-GB or with control milk
(open circles) (10 ml/rinse) twice a day (morning and night) after
brushing for 14 days after an initial 5 days of CPC treatment. The
values are the mean + standard deviation of the ratio of S. mutans to total streptococci expressed as a percentage of the
baseline level. The statistical difference between the baseline level
and the ratio of S. mutans to total streptococci at each
sampling date was assessed using the Mann-Whitney U test. *,
P < 0.1; **, P < 0.05.
|
|
 |
DISCUSSION |
Passive immunization for prevention of dental caries has recently
received much attention (3, 4, 23), and monoclonal antibodies, chicken egg yolk antibodies, and bovine milk antibodies have been used (1, 6, 13, 14). Of these, bovine milk antibodies are, in theory, most easily obtained on a large scale. In
practice, colostrum or concentrated milk has been used in previous studies (1, 13, 17) because of the difficulty of obtaining normal milk containing high titers of antibodies. However, the use of
colostrum as a daily food for humans is prohibited by the Ministry of
Health, Labour and Welfare in Japan, because colostrum contains a large
amount of proteins, including blood cells, readily forms a coagulum on
warming, and is colored. Moreover, the concentration of normal milk
containing low titers of antibodies is a time-consuming job. We have
recently succeeded in preparing large amounts of normal milk in which
the antibody titers to PAc and GTF-I are very high (19).
In this study, we examined the effect of passive immunization with
normal milk containing antibodies against the fusion protein PAcA-GB on
the recolonization of S. mutans in the human oral cavity.
The immune milk significantly inhibited recolonization of S. mutans in saliva and dental plaque. Neither the smell nor the
taste of our immune milk is different from that of control milk. In
this study, none of the volunteers complained of an unpleasant taste or
of being in bad health after rinsing with the immune milk. Passive
immunization with normal immune milk may be useful for control of
S. mutans in humans.
Significant reduction of the resting infection level of S. mutans in the oral cavity is considered to be an effective
starting point at which to assess the subsequent effect of passive
immunization, in which antibodies are administered to test subjects.
Chlorhexidine (CHX) is often used to decrease the S. mutans
level (24, 25). The application of CHX to the mucosal
region, however, is known to be capable of inducing anaphylactic shock
and drug-mediated eruption (18, 21). Therefore, in our
initial intervention, we used CPC, anticipating an antibacterial effect
equivalent to that of CHX (26). It is very difficult to
lower the S. mutans level using only an antibacterial agent,
however, because oral bacteria form biofilms on tooth surfaces
(26). In this study, we combined mechanical cleaning of
the tooth surfaces with the CPC treatment. The combined use of the CPC
treatment and PMTC lowered the S. mutans level effectively.
In our study, the passive immunization period during which the
volunteers were exposed to immune milk was 2 weeks. The S. mutans level in the test group remained lower than that in the control group during the entire 8-week experimental period but increased gradually and approached the baseline by the eighth week
after the beginning of mouth rinsing. It may be necessary to extend the
period of passive immunization to enhance the inhibitory effect of
immune milk on the recolonization of S. mutans.
In the control group, the S. mutans level increased beyond
the baseline level after the CPC treatment. The volunteers rinsed with
nonimmune milk twice a day in the morning and at night after tooth
brushing and, as with the test group, were not to eat or drink for
1 h after rinsing their mouths with milk. Normal milk may contain
various components that enhance the growth of S. mutans or
colonization on teeth by the organism. Long-time stagnation of such
milk components in the oral cavity might increase the number of
S. mutans cells there. Rapid elimination of other oral bacteria by an antibacterial agent may be responsible for the incremental increase of S. mutans. A similar rebound
phenomenon was observed in other studies using CHX (15,
16). Since the concentration of CPC used in this study was
higher than that in commercially available toothpaste and mouth rinse,
most of the subjects complained of taste disorder or a burning
sensation in the oral cavity during the CPC treatment. Such side
effects, however, were temporary, and the symptoms subsided within a
few days after the CPC treatment. Similar side effects have been
reported during clinical research studies using high concentrations of
CHX (25).
In conclusion, bovine milk containing antibody against the fusion
protein PAcA-GB was effective in controlling the recolonization of the
oral cavity by S. mutans. Milk from immunized cattle may be
useful not only for controlling S. mutans in humans who are already infected, but also for preventing initial infection with S. mutans in infancy.
 |
ACKNOWLEDGMENTS |
We thank Takusaburo Ebina of the Division of Immunology, Research
Institute Miyagi Cancer Center, Miyagi, Japan, for helpful suggestions
concerning the immunization method for cows.
This work was supported in part by Grants-in-Aid for Developmental
Scientific Research (A) 12357013 (T.K.) and (C) 11672051 (T.O.) from
the Ministry of Education, Science, Sports and Culture of Japan and by
the Kyushu University Interdisciplinary Programs in Education and
Projects in Research Development (T.K.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Preventive Dentistry, Kyushu University Faculty of Dental Science,
3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Phone:
81-92-642-6350. Fax: 81-92-642-6354. E-mail:
toshidha{at}mbox.nc.kyushu-u.ac.jp.
 |
REFERENCES |
| 1.
|
Filler, S. J.,
R. L. Gregory,
S. M. Michalek,
J. Katz, and J. R. McGhee.
1991.
Effect of immune bovine milk on Streptococcus mutans in human dental plaque.
Arch. Oral Biol.
36:41-47[CrossRef][Medline].
|
| 2.
|
Gold, O. G.,
H. V. Jordan, and J. Van Houte.
1973.
A selective medium for Streptococcus mutans.
Arch. Oral Biol.
18:1357-1364[CrossRef][Medline].
|
| 3.
|
Hajishengallis, G., and S. M. Michalek.
1999.
Current status of a mucosal vaccine against dental caries.
Oral Microbiol. Immunol.
14:1-20[CrossRef][Medline].
|
| 4.
|
Hamada, S., and Y. Kodama.
1996.
Passive immunity for protection against mucosal infections and vaccination for dental caries, p. 187-197.
In
H. Kiyono, P. L. Ogura, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, San Diego, Calif.
|
| 5.
|
Hamada, S., and H. D. Slade.
1980.
Biology, immunology, and cariogenicity of Streptococcus mutans.
Microbiol. Rev.
44:331-384[Free Full Text].
|
| 6.
|
Hatta, H.,
K. Tsuda,
M. Ozeki,
M. Kim,
T. Yamamoto,
S. Otake,
M. Hirasawa,
J. Katz,
N. K. Childers, and S. M. Michalek.
1997.
Passive immunization against dental plaque formation in humans: effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans.
Caries Res.
31:268-274[Medline].
|
| 7.
|
Irvin, R. T., and D. L. Bautista.
1999.
Hope for the post-antibiotic era?
Nat. Biotechnol.
17:20[Medline].
|
| 8.
|
Koga, T.,
H. Asakawa,
N. Okahashi, and S. Hamada.
1986.
Sucrose-dependent cell adherence and cariogenicity of serotype c Streptococcus mutans.
J. Gen. Microbiol.
132:2873-2883[Abstract/Free Full Text].
|
| 9.
|
Koga, T.,
N. Okahashi,
I. Takahashi,
T. Kanamoto,
H. Asakawa, and M. Iwaki.
1990.
Surface hydrophobicity, adherence, and aggregation of cell surface protein antigen mutants of Streptococcus mutans serotype c.
Infect. Immun.
58:289-296[Abstract/Free Full Text].
|
| 10.
|
Koga, T.,
Y. Yamashita,
Y. Nakano,
M. Kawasaki,
T. Oho,
H. Yu,
M. Nakai, and N. Okahashi.
1995.
Surface proteins of Streptococcus mutans.
Dev. Biol. Stand.
85:363-369[Medline].
|
| 11.
|
Kuramitsu, H. K.,
M. Smorawinska,
Y. J. Nakano,
A. Shimamura, and M. Lis.
1995.
Analysis of glucan synthesis by Streptococcus mutans.
Dev. Biol. Stand.
85:303-307[Medline].
|
| 12.
|
Loesche, W. J.
1986.
Role of Streptococcus mutans in human dental decay.
Microbiol. Rev.
50:353-380[Free Full Text].
|
| 13.
|
Loimaranta, V.,
J. Tenovuo,
S. Virtanen,
P. Marnila,
E. L. Syvaoja,
T. Tupasela, and H. Korhonen.
1997.
Generation of bovine immune colostrum against Streptococcus mutans and Streptococcus sobrinus and its effect on glucose uptake and extracellular polysaccharide formation by mutans streptococci.
Vaccine
15:1261-1268[CrossRef][Medline].
|
| 14.
|
Ma, J. K.,
B. Y. Hikmat,
K. Wycoff,
N. D. Vine,
D. Chargelegue,
L. Yu,
M. B. Hein, and T. Lehner.
1998.
Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans.
Nat. Med.
4:601-606[CrossRef][Medline].
|
| 15.
|
Ma, J. K.,
M. Hunjan,
R. Smith, and T. Lehner.
1989.
Specificity of monoclonal antibodies in local passive immunization against Streptococcus mutans.
Clin. Exp. Immunol.
77:331-337[Medline].
|
| 16.
|
Ma, J. K., and T. Lehner.
1990.
Prevention of colonization of Streptococcus mutans by topical application of monoclonal antibodies in human subjects.
Arch. Oral Biol.
35:115S-122S.
|
| 17.
|
Michalek, S. M.,
R. L. Gregory,
C. C. Harmon,
J. Katz,
G. J. Richardson,
T. Hilton,
S. J. Filler, and J. R. McGhee.
1987.
Protection of gnotobiotic rats against dental caries by passive immunization with bovine milk antibodies to Streptococcus mutans.
Infect. Immun.
55:2341-2347[Abstract/Free Full Text].
|
| 18.
|
Moghadam, B. K.,
C. L. Drisko, and R. E. Gier.
1991.
Chlorhexidine mouthwash-induced fixed drug eruption. Case report and review of the literature.
Oral Surg. Oral Med. Oral Pathol.
71:431-434[CrossRef][Medline].
|
| 19.
|
Oho, T.,
Y. Shimazaki,
M. Mitoma,
M. Yoshimura,
Y. Yamashita,
K. Okano,
Y. Nakano,
H. Kawagoe,
M. Fukuyama,
N. Fujihara, and T. Koga.
1999.
Bovine milk antibodies against cell surface protein antigen PAc-glucosyltransferase fusion protein suppress cell adhesion and alter glucan synthesis of Streptococcus mutans.
J. Nutr.
129:1836-1841[Abstract/Free Full Text].
|
| 20.
|
Oho, T.,
Y. Yamashita,
Y. Shimazaki,
M. Kushiyama, and T. Koga.
2000.
Simple and rapid detection of Streptococcus mutans and Streptococcus sobrinus in human saliva by polymerase chain reaction.
Oral Microbiol. Immunol.
15:258-262[CrossRef][Medline].
|
| 21.
|
Okano, M.,
M. Nomura,
S. Hata,
N. Okada,
K. Sato,
Y. Kitano,
M. Tashiro,
Y. Yoshimoto,
R. Hama, and T. Aoki.
1989.
Anaphylactic symptoms due to chlorhexidine gluconate.
Arch. Dermatol.
125:50-52[Abstract/Free Full Text].
|
| 22.
|
Russell, R. R.
1994.
The application of molecular genetics to the microbiology of dental caries.
Caries Res.
28:69-82[Medline].
|
| 23.
|
Smith, D. J., and M. A. Taubman.
1997.
Vaccines against dental caries infection, p. 913-930.
In
M. M. Levine, G. C. Woodrow, J. B. Kaper, and G. S. Cobon (ed.), New generation vaccines. Marcel Dekker, New York, N.Y.
|
| 24.
|
Twetman, S., and L. G. Petersson.
1998.
Comparison of the efficacy of three different chlorhexidine preparations in decreasing the levels of mutans streptococci in saliva and interdental plaque.
Caries Res.
32:113-118[CrossRef][Medline].
|
| 25.
|
Wallman, C.,
B. Krasse,
D. Birkhed, and S. Diacono.
1998.
The effect of monitored chlorhexidine gel treatment on mutans streptococci in margins of restorations.
J. Dent.
26:25-30[CrossRef][Medline].
|
| 26.
|
Wilson, M.,
H. Patel, and J. Fletcher.
1996.
Susceptibility of biofilms of Streptococcus sanguis to chlorhexidine gluconate and cetylpyridinium chloride.
Oral Microbiol. Immunol.
11:188-192[Medline].
|
| 27.
|
Yu, H.,
Y. Nakano,
Y. Yamashita,
T. Oho, and T. Koga.
1997.
Effects of antibodies against cell surface protein antigen PAc-glucosyltransferase fusion proteins on glucan synthesis and cell adhesion of Streptococcus mutans.
Infect. Immun.
65:2292-2298[Abstract].
|
Clinical and Diagnostic Laboratory Immunology, November 2001, p. 1136-1139, Vol. 8, No. 6
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.6.1136-1139.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zhang, P., Jespersgaard, C., Lamberty-Mallory, L., Katz, J., Huang, Y., Hajishengallis, G., Michalek, S. M.
(2002). Enhanced Immunogenicity of a Genetic Chimeric Protein Consisting of Two Virulence Antigens of Streptococcus mutans and Protection against Infection. Infect. Immun.
70: 6779-6787
[Abstract]
[Full Text]